IL6 and cancer: Additionally, since inflammatory mediators such as IL-1β, IL-2, IL-6, and TNF-α have been suggested to contribute to elevated PCT levels [41-43], it is likely that the inflammation occurring during tumorigenesis and cancer progression in colorectal cancer patients also contributes to their elevated PCT levels.